ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,897Medicare Part D Prescriptions Filled, Including Refills

Rank: 379 out of 2170

$440K Total Retail Price of All Prescriptions

Rank: 576 out of 2170

303 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 303 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 303 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 8,186 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
AMLODIPINE BESYLATE 330 297 1 4
LISINOPRIL 323 263 2 3
METOPROLOL SUCCINATE 302 274 3 13
OMEPRAZOLE 290 260 4 2
SIMVASTATIN 287 238 5 1
HYDROCODONE-ACETAMINOPHEN 279 206 S3 6 7
LEVOTHYROXINE SODIUM 223 213 7 5
HYDROCHLOROTHIAZIDE 217 195 8 9
ALLOPURINOL 206 187 9 29
ATENOLOL 195 149 10 23
METFORMIN HCL 188 162 11 8
BISOPROLOL FUMARATE 169 159 12 201
ZOLPIDEM TARTRATE 167 148 13 17
FUROSEMIDE 161 148 14 6
CITALOPRAM HBR 154 116 15 19
SERTRALINE HCL 143 124 16 25
GABAPENTIN 142 81 17 14
METOPROLOL TARTRATE 135 113 18 10
GLIMEPIRIDE 126 88 19 31
SYNTHROID 125 125 20 27
POTASSIUM CHLORIDE 121 117 21 16
TRAMADOL HCL 120 96 22 18
PRAVASTATIN SODIUM 112 99 23 11
BENAZEPRIL HCL 106 98 24 55
NEXIUM 99 46 25 22
CLOPIDOGREL 89 78 26 37
TAMSULOSIN HCL 84 70 27 33
OXYCODONE-ACETAMINOPHEN 78 59 S2 28 60
PREDNISONE 78 54 28 41
ALENDRONATE SODIUM 74 74 30 36
CIPROFLOXACIN HCL 72 65 31 69
SPIRIVA 68 49 32 49
RANITIDINE HCL 67 63 33 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 53 34 20
DONEPEZIL HCL 65 61 35 32
CRESTOR 65 58 35 24
PLAVIX 65 56 35 58
TRICOR 62 16 38 130
FLUOXETINE HCL 61 55 39 59
PANTOPRAZOLE SODIUM 61 50 39 39
BYSTOLIC 61 46 39 138
ADVAIR DISKUS 59 53 42 45
NAPROXEN 58 46 43 107
ATORVASTATIN CALCIUM 57 51 44 12
LANTUS 57 49 44 51
ETODOLAC 57 48 44 218
ORPHENADRINE CITRATE 55 47 R 47 349
BACLOFEN 55 13 47 137
CEFUROXIME 55 50 47 175
WARFARIN SODIUM 52 47 50 15
PREMARIN 51 40 R 51 145
DOXAZOSIN MESYLATE 50 50 52 93
NAMENDA 50 50 52 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 13, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.